THE FELDER DOCTRINE: PHYSICALLY REMOVE THE PATHOPHYSIOLOGIC BASIS OF THE DISEASE. Trademark

Trademark Overview


On Thursday, April 22, 2021, a trademark application was filed for THE FELDER DOCTRINE: PHYSICALLY REMOVE THE PATHOPHYSIOLOGIC BASIS OF THE DISEASE. with the United States Patent and Trademark Office. The USPTO has given the THE FELDER DOCTRINE: PHYSICALLY REMOVE THE PATHOPHYSIOLOGIC BASIS OF THE DISEASE. trademark a serial number of 90664518. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 14, 2022. The THE FELDER DOCTRINE: PHYSICALLY REMOVE THE PATHOPHYSIOLOGIC BASIS OF THE DISEASE. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of immunopharmaceuticals, biotechnology, pharmaceutical research and development and genetic science, and treatments; Research and development of vaccines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Research on the subject of pharmaceuticals
the felder doctrine: physically remove the pathophysiologic basis of the disease.

General Information


Serial Number90664518
Word MarkTHE FELDER DOCTRINE: PHYSICALLY REMOVE THE PATHOPHYSIOLOGIC BASIS OF THE DISEASE.
Filing DateThursday, April 22, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Section 2(f) Limitation StatementFELDER has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
Goods and ServicesResearch and development in the field of immunopharmaceuticals, biotechnology, pharmaceutical research and development and genetic science, and treatments; Research and development of vaccines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Research on the subject of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 29, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressJackson Center, PA 16133

Trademark Events


Event DateEvent Description
Wednesday, December 14, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 14, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 14, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, June 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Thursday, April 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Thursday, July 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 26, 2021NEW APPLICATION ENTERED IN TRAM